Karyopharm Therapeutics (KPTI) Tops Q2 EPS by 5c ; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall St dips after AI-led selloff; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude hits more than five-month high on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| KARYOPHARM THERAP (NASDAQ: KPTI) | Delayed: 0.48 -0.07 (12.73%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.55 | 52 Week High | $19.41 | |||
| Open | $0.54 | 52 Week Low | $4.83 | |||
| Day High | $0.56 | P/E | N/A | |||
| Day Low | $0.48 | EPS | $-2.74 | |||
| Volume | 492,052 | |||||
